The global nasal spray market is experiencing robust growth, driven by various positive factors. The increasing prevalence of nasal allergies, sinusitis, and rhinitis, coupled with growing awareness about the benefits of nasal spray for quick relief, fuels market demand. Technological advancements and innovative formulations enhance the effectiveness and convenience of nasal sprays. Furthermore, favorable government initiatives and investments in healthcare infrastructure support market growth. With a focus on improving patient outcomes and providing non-invasive treatment options, the global nasal spray market is poised for continued expansion, benefiting individuals worldwide.
Access full Report @ https://www.databridgemarketresearch.com/reports/global-nasal-spray-market
Data Bridge Market Research analyses that the Nasal Spray Market is expected to grow at a value of USD 38,026.75 million by 2030, at a CAGR of 6.7% from USD 22634.65 in 2022 during the forecast period from 2023 to 2030. There is a greater awareness among individuals regarding the benefits of nasal spray for relieving symptoms such as congestion, runny nose, and nasal irritation. This increased awareness, coupled with the acceptance of nasal spray as a convenient and non-invasive treatment option, fuels market growth.
Key Findings of the Study
Expansion of over-the-counter (OTC) availability is expected to drive the market's growth rate
The expansion of over-the-counter (OTC) availability for nasal spray products has played a significant role in boosting market growth. Making nasal sprays accessible without the need for a prescription, has increased convenience for consumers, allowing them to purchase these products easily from pharmacies or retail outlets. This easy accessibility has widened the consumer base, leading to increased usage and driving market growth for nasal spray products in the treatment of nasal congestion and related conditions.
Report Scope and Market Segmentation
Report Metric
|
Details
|
Forecast Period
|
2023 to 2030
|
Base Year
|
2022
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
Segments Covered
|
Product Type (Decongestion Nasal Spray, Steroid Nasal Spray, Salt Water Solution/Saline Nasal Spray, and Others), Container Design (Pump Bottles and Pressurized Canisters), Dosage Form (Multi Dose, Unit/Single Dose, and Bi Dose), Therapeutic Class (Antihistamine, Nasal Steroid, Mast Cell Inhibitor, and Anticholinergic), Application (Nasal Congestion, Allergic and Non-Allergic Rhinitis, Central Nervous System Disorders, Vaccination, and Others), Prescription/Availability (Over The Counter and Prescribed), End User (Home Care Settings, Hospitals, Clinics, and Community Health Care)
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
Market Players Covered
|
EMERGENT (U.S.), Cipla Inc. (India), Sandoz International GmbH (A Part of Novartis) (Switzerland), Aytu Health (A subsidiary of Aytu BioPharma, Inc.) (U.S.), Bayer AG (Germany), GlaxoSmithKline plc. (U.K.), Assertio Therapeutics, Inc. (U.S.), Aurena Laboratories (Sweden), J Pharmaceuticals (U.S.), St. Renatus (U.S.), Ultratech India Limited (India), Catalent, Inc. (U.S.), Teva Pharmaceuticals USA, Inc. (Israel), Pfizer Inc. (U.S.), Viatris Inc. (U.S.), LEEFORD HEALTHCARE LTD (India), Aishwarya Group (India) among others
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The nasal spray market is segmented on the basis of product type, container design, dosage form, therapeutic class, application, prescription/ availability, and end user
- On the basis of product type, the nasal spray market is segmented into decongestion nasal spray, steroid nasal spray, salt water solution/saline nasal spray, and others. The decongestion nasal spray segment is expected to dominate the global nasal spray market with 47.3% market share owing to its capability to instantly relieve nasal congestion brought on by allergies, colds, or sinus problems. It is a popular option for people looking for quick and targeted relief from nasal congestion due to its fast-acting nature and targeted application in the forecast period of 2023 to 2030.
In 2023, the decongestion nasal spray segment is expected to dominate the global nasal spray market
In 2023, the decongestion nasal spray segment is expected to dominate the global nasal spray market with 47.3% market share owing to its effectiveness in providing immediate relief from nasal congestion caused by allergies, colds, or sinus issues. Its fast-acting nature and targeted application make it a popular choice for individuals seeking quick and targeted relief from nasal congestion in the forecast period of 2023 to 2030.
- On the basis of container design, the nasal spray market is segmented into pump bottles and pressurized canisters. The pump bottles segment is expected to dominate the global nasal spray market with 67.3% market share due to their convenience and ease of use. The pump mechanism allows for controlled and precise dispensing of the nasal spray, ensuring accurate dosing and minimizing waste in the forecast period of 2023 to 2030.
- On the basis of dosage form, the nasal spray market is segmented into multi dose, unit/single dose, and bi dose. Multi dose segment is expected to dominate the dosage form segment of the global nasal spray market with 46.7% market share owing to convenience, cost-effectiveness, and improved medication adherence. They allow for multiple doses to be dispensed from a single container, ensuring prolonged therapy and ease of use for patients.
In 2023, Multi dose segment is expected to dominate the dosage form segment of the global nasal spray market
In 2023, Multi dose segment is expected to dominate the dosage form segment of the global nasal spray market owing to improved medication adherence, cost-effectiveness, and convenience. They ensure prolonged therapy and patient convenience by enabling multiple doses to be dispensed from a single container with 46.7% market share in the forecast period of 2023 to 2030.
- On the basis of therapeutic class, the nasal spray market is segmented into antihistamine, nasal steroid, mast cell inhibitor, and anticholinergic. The antihistamine segment is expected to dominate the global nasal spray market with 48.8% market share due to itching, and nasal congestion. Antihistamines work by blocking the action of histamine, a chemical released during allergic reactions, providing significant relief to individuals with allergic conditions in the forecast period of 2023 to 2030.
- On the basis of application, the nasal spray market is segmented into nasal congestion, allergic and non-allergic rhinitis, central nervous system disorders, vaccination, and others. The nasal congestion segment is expected to dominate the global nasal spray market with 40.0% market share due to the widespread prevalence of nasal congestion caused by allergies, colds, sinusitis, and other respiratory conditions. Nasal sprays targeting congestion offer quick relief and improved breathing, making them highly sought after by consumers in the forecast period of 2023 to 2030.
- On the basis of prescription/availability, the nasal spray market is segmented into over the counter and prescribed. The prescribed segment is expected to dominate the global nasal spray market with 72.0% market share due to the regulatory requirements for obtaining topical corticosteroids. Prescription-based distribution ensures proper evaluation, diagnosis, and personalized treatment plans by healthcare professionals, ensuring safety and efficacy in patient care in the forecast period of 2023 to 2030.
- 최종 사용자를 기준으로 비강 스프레이 시장은 가정 간병 환경, 병원, 진료소 및 지역 사회 건강 관리로 세분화됩니다. 가정 간병 환경 부문은 자가 관리의 증가 추세와 다양한 피부 질환에 대해 집에서 국소 코르티코스테로이드를 투여하는 편의성으로 인해 2023년에서 2030년까지의 예측 기간 동안 환자들에게 편안함과 안정감을 제공함으로써 글로벌 비강 스프레이 시장을 45.4%의 시장 점유율로 지배할 것으로 예상됩니다.
주요 플레이어
Data Bridge Market Research는 비강 스프레이 시장의 주요 기업으로 Bayer AG(독일), GlaxoSmithKline plc.(영국), Assertio Therapeutics, Inc.(미국), Aurena Laboratories(스웨덴), J Pharmaceuticals(미국), St. Renatus(미국)를 꼽았습니다.
시장 개발
- 글로벌 헬스케어 기업인 Viatris Inc.(NASDAQ: VTRS)는 오늘 Oyster Point Pharma와 Famy Life Sciences의 인수를 완료하여 새로운 Viatris Eye Care 사업부를 설립한다고 발표했습니다.
- 2023년, Teva Pharmaceutical Industries Ltd의 미국 계열사인 Teva Pharmaceuticals는 미국에서 Revlimid1(레날리도마이드 캡슐) 제네릭 버전의 추가 강도를 2.5mg 및 20mg 강도로 출시한다고 발표했습니다. 이 제품 출시는 회사의 제품 포트폴리오 확장에 도움이 될 것입니다.
지역 분석
지리적으로 비강 스프레이 시장 보고서에서 다루는 국가는 북미의 미국, 캐나다 및 멕시코, 유럽의 독일, 프랑스, 영국, 네덜란드, 스위스, 벨기에, 러시아, 이탈리아, 스페인, 터키, 유럽의 기타 유럽, 중국, 일본, 인도, 한국, 싱가포르, 말레이시아, 호주, 태국, 인도네시아, 필리핀, 아시아 태평양(APAC)의 기타 아시아 태평양(APAC), 사우디 아라비아, UAE, 남아프리카 공화국, 이집트, 이스라엘, 중동 및 아프리카(MEA)의 일부인 기타 중동 및 아프리카(MEA), 남미의 일부인 기타 남미, 브라질, 아르헨티나입니다.
Data Bridge Market Research 분석에 따르면:
북미는 2023-2030년 예측 기간 동안 비강 스프레이 시장 에서 지배적인 지역입니다.
북미 지역이 세계 비강 스프레이 시장에서 우위를 점하는 것은 비강 스프레이 제품에 대한 투자 증가로 시장 성장이 촉진된 데 기인합니다. 특히 미국은 주요 기업들의 탄탄한 입지와 광범위한 유통망을 바탕으로 북미 시장을 선도하고 있습니다. 탄탄한 연구 개발 투자와 유리한 규제 체계는 지속적인 혁신과 제품 개발을 가능하게 하며, 미국이 비강 스프레이 시장에서 주도적인 입지를 굳건히 하는 데 기여합니다.
유럽은 2023-2030년 예측 기간 동안 비강 스프레이 시장에서 가장 빠르게 성장하는 지역으로 추정됩니다.
독일은 여러 요인으로 인해 유럽 비강 스프레이 시장에서 지배적인 위치를 차지하고 있습니다. 독일은 유럽 전역의 신흥 시장에서 비강 스프레이 제품에 대한 수요 증가의 수혜를 받고 있습니다. 또한, 독일 제조업체들은 강력한 입지와 광범위한 유통망을 갖추고 있어 증가하는 시장 수요에 효과적으로 대응할 수 있습니다. 의료 인프라 확충과 유리한 규제 정책은 독일 비강 스프레이 시장의 성장을 더욱 뒷받침하며, 이 지역에서 독일의 지배력을 더욱 공고히 하고 있습니다.
비강 스프레이 시장 보고서 에 대한 자세한 내용은 여기를 클릭하세요 - https://www.databridgemarketresearch.com/reports/global-nasal-spray-market
